Phase 2 Study Of Bendamustine, Bortezomib (Velcade) and Prednisone (BVP) For Newly Diagnosed Multiple Myeloma (MM)
Autor: | Mateos, Maria-Victoria, Oriol, Albert *, Rosiñol, Laura *, de Arriba, Felipe *, Martín, Jesús *, Martínez-López, Joaquín *, Echeveste, Maria Asuncion *, Sarrá, Josep *, Ramirez, Gemma *, Ocio, Enrique M. *, Martinez, Rafael *, Palomera, Luis *, Payer, Angel *, Iglesias, Rebeca *, De La Rubia, Javier *, Alegre, Adrian, Chinea, Anabelle *, Bladé, Joan, Lahuerta, Juan José *, San Miguel, Jesús F |
---|---|
Zdroj: | In Blood 15 November 2013 122(21):2155-2155 |
Databáze: | ScienceDirect |
Externí odkaz: |